Constellation Brands Inc (STZ) concluded trading on Thursday at a closing price of $172.33, with 4.44 million shares of worth about $765.58 million changed hands on the day. Half year performance of the stock remained negative as price took a plunge of -29.07% during that period and on February 20, 2025 the price saw a loss of about -0.05%. Currently the company’s common shares owned by public are about 180.70M shares, out of which, 138.79M shares are available for trading.
Stock saw a price change of 7.00% in past 5 days and over the past one month there was a price change of -5.87%. Year-to-date (YTD), STZ shares are showing a performance of -22.02% which decreased to -29.33% when we look at its performance for past 12 months. Over the period of past 52 weeks, stock dropped to lowest price of $160.46 but also hit the highest price of $274.87 during that period. The average intraday trading volume for Constellation Brands Inc shares is 2.23 million. The stock is currently trading -0.73% below its 20-day simple moving average (SMA20), while that difference is down -13.59% for SMA50 and it goes to -26.72% lower than SMA200.
Constellation Brands Inc (NYSE: STZ) currently have 180.70M outstanding shares and institutions hold larger chunk of about 81.99% of that.
The stock has a current market capitalization of $31.14B and its 3Y-monthly beta is at 0.89. PE ratio of stock for trailing 12 months is 46.14, while it has posted earnings per share of $3.73 in the same period. Its PEG reads 4.93 and has Quick Ratio of 0.46 while making debt-to-equity ratio of 1.55. Volatility of a stock is a metric used to know how much the price of that stock is under influence and for STZ, volatility over the week remained 2.64% while standing at 2.60% over the month.
Stock’s fiscal year EPS is expected to rise by 11.93% while it is estimated to increase by 7.52% in next year. EPS is likely to grow at an annualized rate of 9.35% for next 5-years, compared to annual growth of -11.78% made by the stock over the past 5-years.
Digging deeper we find that several firms have released their research notes about the support levels of the stock. Most recent of them is a note released by Piper Sandler on February 03, 2025 offering a Neutral rating for the stock and assigned a target price range of between $245 and $200 to it. On January 13, 2025, JP Morgan Downgrade their recommendations, while on January 13, 2025, Jefferies Downgrade their ratings for the stock with a price target of $201. Stock get a Buy rating from Needham on December 06, 2024.
